1. Venaxis acquires Boulder biotech

    Venaxis acquires Boulder biotech

    Venaxis Inc., a Castle Rock medical device company, said it's acquired BiOptix Diagnostics Inc. of Boulder. Venaxis (Nasdaq: APPY) said in a Securities and Exchange Commission filing that it's paying "627,010 shares of Venaxis common stock with an aggregate value of $1,950,000" for BiOptix. BiOptix uses technology developed by Dr. John 'Jan' Hall, a professor at the University of Colorado, who shared the Nobel Prize for Physics in 2005...

    Read Full Article
  1. Authors

  2. Categories

    1. Feeds:

      CTA Members Press Releases, CTA Tech Tour, Government & Policy, Tech Workforce & Education
    2. Tags:

      B2B Software, Big Data & Analytics, Business Services Provider, Cloud, Community Organizations, Consumer Software, Development, Energy Tech, Enterprise, Government, Hardware, Health IT, Innovation & Entrepreneurship, Internet of Things, Mobile, Security, Startups, Telecom, Women In Tech